650 related articles for article (PubMed ID: 18443241)
1. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
[TBL] [Abstract][Full Text] [Related]
2. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice.
Baumhäkel M; Custodis F; Schlimmer N; Laufs U; Böhm M
Atherosclerosis; 2010 Sep; 212(1):55-62. PubMed ID: 20347444
[TBL] [Abstract][Full Text] [Related]
3. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M
J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress.
Kröller-Schön S; Schulz E; Wenzel P; Kleschyov AL; Hortmann M; Torzewski M; Oelze M; Renné T; Daiber A; Münzel T
Basic Res Cardiol; 2011 Nov; 106(6):1147-58. PubMed ID: 21964558
[TBL] [Abstract][Full Text] [Related]
5. Heart rate reduction by ivabradine improves aortic compliance in apolipoprotein E-deficient mice.
Custodis F; Fries P; Müller A; Stamm C; Grube M; Kroemer HK; Böhm M; Laufs U
J Vasc Res; 2012; 49(5):432-40. PubMed ID: 22759927
[TBL] [Abstract][Full Text] [Related]
6. Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis.
Schirmer SH; Degen A; Baumhäkel M; Custodis F; Schuh L; Kohlhaas M; Friedrich E; Bahlmann F; Kappl R; Maack C; Böhm M; Laufs U
Eur Heart J; 2012 May; 33(10):1223-31. PubMed ID: 21821843
[TBL] [Abstract][Full Text] [Related]
7. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
[TBL] [Abstract][Full Text] [Related]
8. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
9. Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis.
Laufs U; Wassmann S; Czech T; Münzel T; Eisenhauer M; Böhm M; Nickenig G
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):809-14. PubMed ID: 15692095
[TBL] [Abstract][Full Text] [Related]
10. High-cholesterol diet augments endothelial dysfunction via elevated oxidative stress and reduced tetrahydrobiopterin in Ins2(Akita) mice, an autosomal dominant mutant type 1 diabetic model.
Yang XQ; Chen AF
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):764-9. PubMed ID: 19207718
[TBL] [Abstract][Full Text] [Related]
11. Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects.
Okabe TA; Shimada K; Hattori M; Murayama T; Yokode M; Kita T; Kishimoto C
Cardiovasc Res; 2007 Jun; 74(3):537-45. PubMed ID: 17374527
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
13. Improvement of endothelial function by systemic transfusion of vascular progenitor cells.
Wassmann S; Werner N; Czech T; Nickenig G
Circ Res; 2006 Oct; 99(8):e74-83. PubMed ID: 16990568
[TBL] [Abstract][Full Text] [Related]
14. High sodium intake increases vascular superoxide formation and promotes atherosclerosis in apolipoprotein E-deficient mice.
Ketonen J; Merasto S; Paakkari I; Mervaala EM
Blood Press; 2005; 14(6):373-82. PubMed ID: 16403692
[TBL] [Abstract][Full Text] [Related]
15. A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Matsubara J; Sugiyama S; Sugamura K; Nakamura T; Fujiwara Y; Akiyama E; Kurokawa H; Nozaki T; Ohba K; Konishi M; Maeda H; Izumiya Y; Kaikita K; Sumida H; Jinnouchi H; Matsui K; Kim-Mitsuyama S; Takeya M; Ogawa H
J Am Coll Cardiol; 2012 Jan; 59(3):265-76. PubMed ID: 22240132
[TBL] [Abstract][Full Text] [Related]
16. The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice.
Pöss J; Werner C; Lorenz D; Gensch C; Böhm M; Laufs U
Basic Res Cardiol; 2010 Nov; 105(6):725-35. PubMed ID: 20857126
[TBL] [Abstract][Full Text] [Related]
17. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
18. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo.
Pelat M; Dessy C; Massion P; Desager JP; Feron O; Balligand JL
Circulation; 2003 May; 107(19):2480-6. PubMed ID: 12719275
[TBL] [Abstract][Full Text] [Related]
20. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]